Bayer AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000BAY0017
EUR
45.80
0.98 (2.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.24 M

Shareholding (Sep 2025)

FII

0.07%

Held by 1 FIIs

DII

99.93%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

High Debt company with Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of 1.21% and Operating profit at -6.41% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 44,995 Million ()

stock-summary
P/E

9.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.22

stock-summary
Return on Equity

10.34%

stock-summary
Price to Book

1.52

Revenue and Profits:
Net Sales:
10,739 Million
(Quarterly Results - Jun 2025)
Net Profit:
-190 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
72.76%
0%
72.76%
6 Months
83.38%
0%
83.38%
1 Year
115.83%
0%
115.83%
2 Years
56.82%
0%
56.82%
3 Years
-21.29%
0%
-21.29%
4 Years
-12.96%
0%
-12.96%
5 Years
-17.92%
0%
-17.92%

Bayer AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
1.70%
EBIT Growth (5y)
46.22%
EBIT to Interest (avg)
2.34
Debt to EBITDA (avg)
3.73
Net Debt to Equity (avg)
1.09
Sales to Capital Employed (avg)
0.59
Tax Ratio
5.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
8.66%
ROE (avg)
15.91%

Valuation key factors

Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.87
EV to EBIT
12.05
EV to EBITDA
7.31
EV to Capital Employed
0.94
EV to Sales
1.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.78%
ROE (Latest)
9.45%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.07%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -3.63% vs 0.91% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -630.77% vs 98.62% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,739.00",
          "val2": "11,144.00",
          "chgp": "-3.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,857.00",
          "val2": "2,072.00",
          "chgp": "-10.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "495.00",
          "val2": "682.00",
          "chgp": "-27.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,002.00",
          "val2": "-514.00",
          "chgp": "-94.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-190.00",
          "val2": "-26.00",
          "chgp": "-630.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "147.60%",
          "val2": "83.50%",
          "chgp": "6.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.16% vs -6.11% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.46% vs -170.62% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "46,606.00",
          "val2": "47,637.00",
          "chgp": "-2.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8,529.00",
          "val2": "12,342.00",
          "chgp": "-30.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,959.00",
          "val2": "1,735.00",
          "chgp": "12.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6,368.00",
          "val2": "-7,606.00",
          "chgp": "16.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2,546.00",
          "val2": "-2,942.00",
          "chgp": "13.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "96.10%",
          "val2": "176.50%",
          "chgp": "-8.04%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary

Jun'25
Jun'24
Change(%)
Net Sales
10,739.00
11,144.00
-3.63%
Operating Profit (PBDIT) excl Other Income
1,857.00
2,072.00
-10.38%
Interest
495.00
682.00
-27.42%
Exceptional Items
-1,002.00
-514.00
-94.94%
Consolidate Net Profit
-190.00
-26.00
-630.77%
Operating Profit Margin (Excl OI)
147.60%
83.50%
6.41%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -3.63% vs 0.91% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -630.77% vs 98.62% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
46,606.00
47,637.00
-2.16%
Operating Profit (PBDIT) excl Other Income
8,529.00
12,342.00
-30.89%
Interest
1,959.00
1,735.00
12.91%
Exceptional Items
-6,368.00
-7,606.00
16.28%
Consolidate Net Profit
-2,546.00
-2,942.00
13.46%
Operating Profit Margin (Excl OI)
96.10%
176.50%
-8.04%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -2.16% vs -6.11% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 13.46% vs -170.62% in Dec 2023

stock-summaryCompany CV
About Bayer AG stock-summary
stock-summary
Bayer AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available